Skip to Main Content

Paper Details

Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer.
Clin Oncol (R Coll Radiol)
6
2020
Author NameAffiliation
Andrew LoblawOdette Cancer Center, University of Toronto, Canada Institute of Health Care Policy
  • 1 - 1

Datasets

Release 1.2